| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |